MapLight Therapeutics Inc (MPLT) Price Prediction & ForecastMPLTMapLight Therapeutics Inc

Alphio's MPLT stock price prediction model matches the current MapLight Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $8.06 (+1.17%). The 1-week path is $8.33 (+4.52%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

MapLight Therapeutics is not a good buy right now due to its current price of $7.70, which is significantly below analyst targets, including a downgrade to $13 by UBS. The stock has a very low RSI of 17.75, indicating it is oversold, but the negative momentum and substantial losses of 54.08% year-to-date suggest further declines are likely. The main risk is the company's ongoing negative net income, which reached -79,548,000 USD in Q4 2025, indicating financial instability.

MapLight Therapeutics Inc (MPLT) last closed at $7.97, losing -3.39%. These facts feed the 1-day and 1-week MPLT price prediction above.